Unichem Laboratories, 506690, UNICHEMLAB Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,353.66
68.57
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,371.84
1.20%
0.92

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

3.50
-4.32
1.30

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-2.39
-12.97
-

PAT CAGR (%)

10 Years
5 Years
3 Years

-6.95
-20.40
83.17

P:E (Median)

8 Years
5 Years
3 Years

16.30
0.63
-

P:BV (Average)

8 Years
5 Years
3 Years

1.91
1.58
0.59

EV:EBITDA (Average)

8 Years
5 Years
3 Years

20.14
24.97
33.93

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var%
Net Sales 261.09 215.63 21.08% 311.18 231.19 34.60% 310.93 225.10 38.13% 240.77 232.52 3.55%
Expenses 233.29 226.60 2.95% 279.54 256.90 8.81% 267.09 260.92 2.36% 248.58 250.63 -0.82%
EBITDA 27.79 -10.98 - 31.64 -25.70 - 43.84 -35.82 - -7.81 -18.11 -
EBIDTM 10.65% -5.09% 10.17% -11.12% 14.10% -15.91% -3.24% -7.79%
Other Income 4.91 19.13 -74.33% 13.32 23.01 -42.11% 10.41 29.05 -64.17% 18.73 27.98 -33.06%
Interest 0.37 0.59 -37.29% 0.61 0.42 45.24% 0.16 0.23 -30.43% 0.16 0.05 220.00%
Depreciation 19.90 19.11 4.13% 18.75 17.26 8.63% 18.93 17.86 5.99% 18.31 16.86 8.60%
PBT 12.43 -11.54 - 25.61 -20.37 - 35.16 -24.86 - -7.55 -7.03 -
Tax 11.56 0.00 0 -4.82 0.00 - 4.82 0.00 0 0.00 -7.50 -
PAT 0.86 -11.54 - 30.43 -20.37 - 30.34 -24.86 - -7.55 0.47 -
PATM 0.33% -5.35% 9.78% -8.81% 9.76% -11.05% -3.13% 0.20%
EPS 0.12 -1.64 - 4.32 -2.89 - 4.31 -3.53 - -1.07 0.07 -

Description Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var%
Net Sales 274.12 290.20 -5.54% 326.28 274.83 18.72% 317.51 268.14 18.41% 317.27 273.20 16.13%
Expenses 255.07 276.83 -7.86% 296.17 291.99 1.43% 287.65 294.94 -2.47% 305.19 293.42 4.01%
EBITDA 19.05 13.36 42.59% 30.12 -17.16 - 29.86 -26.81 - 12.08 -20.22 -
EBIDTM 6.95% 4.60% 9.23% -6.24% 9.40% -10.00% 3.81% -7.40%
Other Income 7.83 11.82 -33.76% 15.61 25.10 -37.81% 10.04 28.13 -64.31% 16.71 26.26 -36.37%
Interest 1.81 2.40 -24.58% 1.27 2.32 -45.26% 0.79 1.86 -57.53% 1.25 1.28 -2.34%
Depreciation 21.87 22.96 -4.75% 20.82 19.47 6.93% 21.13 20.98 0.71% 20.54 18.25 12.55%
PBT 3.19 -0.17 - 23.64 -13.85 - 17.98 -21.51 - 7.00 -13.49 -
Tax 3.37 17.63 -80.88% -0.07 1.20 - 9.25 0.68 1,260.29% 4.61 -7.53 -
PAT -0.17 -17.80 - 23.71 -15.05 - 8.74 -22.19 - 2.39 -5.96 -
PATM -0.06% -6.13% 7.27% -5.48% 2.75% -8.27% 0.75% -2.18%
EPS -0.06 -2.44 - 3.35 -2.07 - 1.24 -3.15 - 0.35 -0.88 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales - 1,123.97 904.44 975.88 1,231.38 1,418.41 1,220.52 1,090.98 1,044.17 1,005.22 803.19 Net Sales Growth - 24.27% -7.32% -20.75% -13.19% 16.21% 11.87% 4.48% 3.87% 25.15% Cost Of Goods Sold - 359.33 311.23 339.36 274.57 188.07 395.62 375.39 327.82 335.81 263.68 Gross Profit - 764.64 593.21 636.52 956.81 1,230.34 824.90 715.59 716.36 669.41 539.51 GP Margin - 68.03% 65.59% 65.23% 77.70% 86.74% 67.59% 65.59% 68.61% 66.59% 67.17% Total Expenditure - 1,028.51 995.05 1,034.20 1,214.03 1,252.60 1,078.24 989.74 863.16 823.08 678.06 Power & Fuel Cost - 67.95 72.14 75.43 48.26 40.76 37.34 38.36 34.96 30.55 25.45 % Of Sales - 6.05% 7.98% 7.73% 3.92% 2.87% 3.06% 3.52% 3.35% 3.04% 3.17% Employee Cost - 234.04 205.16 176.76 146.54 117.68 209.60 178.04 147.14 128.01 104.88 % Of Sales - 20.82% 22.68% 18.11% 11.90% 8.30% 17.17% 16.32% 14.09% 12.73% 13.06% Manufacturing Exp. - 138.10 139.62 136.04 115.50 90.53 132.41 129.61 121.78 106.97 91.99 % Of Sales - 12.29% 15.44% 13.94% 9.38% 6.38% 10.85% 11.88% 11.66% 10.64% 11.45% General & Admin Exp. - 164.37 196.55 200.15 566.05 722.03 145.52 132.64 108.27 84.16 72.03 % Of Sales - 14.62% 21.73% 20.51% 45.97% 50.90% 11.92% 12.16% 10.37% 8.37% 8.97% Selling & Distn. Exp. - 61.44 66.88 87.17 52.96 65.40 132.40 127.44 120.75 125.03 110.10 % Of Sales - 5.47% 7.39% 8.93% 4.30% 4.61% 10.85% 11.68% 11.56% 12.44% 13.71% Miscellaneous Exp. - 3.28 3.48 19.29 10.15 28.13 25.35 8.26 2.44 12.55 110.10 % Of Sales - 0.29% 0.38% 1.98% 0.82% 1.98% 2.08% 0.76% 0.23% 1.25% 1.24% EBITDA - 95.46 -90.61 -58.32 17.35 165.81 142.28 101.24 181.01 182.14 125.13 EBITDA Margin - 8.49% -10.02% -5.98% 1.41% 11.69% 11.66% 9.28% 17.34% 18.12% 15.58% Other Income - 47.37 99.17 101.54 3,280.20 7.19 22.71 20.31 42.96 17.61 11.69 Interest - 1.30 1.28 0.62 3.17 2.00 2.29 2.37 2.48 2.48 3.30 Depreciation - 75.89 71.09 61.71 45.04 39.41 34.99 37.68 42.67 34.82 28.29 PBT - 65.65 -63.81 -19.11 3,249.34 131.60 127.70 81.50 178.82 162.45 105.24 Tax - 11.56 -7.50 -27.91 692.74 27.73 23.69 17.10 43.00 32.85 22.77 Tax Rate - 17.61% 11.75% 146.05% 21.32% 21.07% 19.08% 20.98% 24.05% 20.22% 21.64% PAT - 54.08 -56.32 8.80 2,556.60 103.87 100.48 64.40 135.82 129.60 82.46 PAT before Minority Interest - 54.08 -56.32 8.80 2,556.60 103.87 100.48 64.40 135.82 129.60 82.46 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - 4.81% -6.23% 0.90% 207.62% 7.32% 8.23% 5.90% 13.01% 12.89% 10.27% PAT Growth - - - -99.66% 2,361.35% 3.37% 56.02% -52.58% 4.80% 57.17% EPS - 7.68 -8.00 1.25 363.15 14.75 14.27 9.15 19.29 18.41 11.71

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales - 1,235.14 1,103.71 1,188.19 1,379.90 1,540.06 1,332.65 1,201.79 1,133.45 1,080.80 875.46 Net Sales Growth - 11.91% -7.11% -13.89% -10.40% 15.56% 10.89% 6.03% 4.87% 23.46% Cost Of Goods Sold - 302.14 308.63 364.19 274.97 188.77 386.97 378.57 332.84 343.06 278.55 Gross Profit - 933.00 795.08 823.99 1,104.93 1,351.28 945.67 823.23 800.61 737.75 596.91 GP Margin - 75.54% 72.04% 69.35% 80.07% 87.74% 70.96% 68.50% 70.63% 68.26% 68.18% Total Expenditure - 1,144.03 1,154.53 1,269.21 1,358.21 1,357.62 1,168.77 1,100.79 955.75 910.06 759.42 Power & Fuel Cost - 68.89 73.02 76.39 49.23 41.62 38.25 39.39 35.97 31.36 26.22 % Of Sales - 5.58% 6.62% 6.43% 3.57% 2.70% 2.87% 3.28% 3.17% 2.90% 2.99% Employee Cost - 306.97 273.28 238.52 200.64 169.04 255.92 223.20 187.37 164.88 140.06 % Of Sales - 24.85% 24.76% 20.07% 14.54% 10.98% 19.20% 18.57% 16.53% 15.26% 16.00% Manufacturing Exp. - 215.73 232.08 147.23 125.30 103.70 150.54 145.03 137.05 119.15 101.54 % Of Sales - 17.47% 21.03% 12.39% 9.08% 6.73% 11.30% 12.07% 12.09% 11.02% 11.60% General & Admin Exp. - 123.98 147.90 229.37 594.53 744.66 167.66 153.29 127.77 104.73 88.54 % Of Sales - 10.04% 13.40% 19.30% 43.09% 48.35% 12.58% 12.76% 11.27% 9.69% 10.11% Selling & Distn. Exp. - 122.52 116.12 197.24 108.38 107.77 166.84 157.12 134.03 135.93 116.00 % Of Sales - 9.92% 10.52% 16.60% 7.85% 7.00% 12.52% 13.07% 11.82% 12.58% 13.25% Miscellaneous Exp. - 3.81 3.50 16.26 5.16 2.06 2.58 4.19 0.73 10.97 116.00 % Of Sales - 0.31% 0.32% 1.37% 0.37% 0.13% 0.19% 0.35% 0.06% 1.01% 0.97% EBITDA - 91.11 -50.82 -81.02 21.69 182.44 163.88 101.00 177.70 170.74 116.04 EBITDA Margin - 7.38% -4.60% -6.82% 1.57% 11.85% 12.30% 8.40% 15.68% 15.80% 13.25% Other Income - 50.19 91.31 98.41 3,278.19 5.50 19.11 20.72 42.38 16.96 12.50 Interest - 5.12 7.85 7.52 8.01 3.36 2.90 3.04 3.19 3.29 4.08 Depreciation - 84.36 81.67 67.37 50.51 43.52 38.79 41.27 45.72 38.34 30.43 PBT - 51.82 -49.02 -57.50 3,241.36 141.07 141.31 77.41 171.17 146.07 94.03 Tax - 17.15 11.97 -33.64 696.23 32.58 29.30 2.13 43.00 32.85 22.77 Tax Rate - 33.10% -24.42% 58.50% 21.48% 23.09% 21.27% 2.75% 25.12% 22.49% 24.22% PAT - 34.67 -61.00 -23.87 2,545.13 108.49 108.48 75.28 128.16 113.23 71.26 PAT before Minority Interest - 34.67 -61.00 -23.87 2,545.13 108.49 108.48 75.28 128.16 113.23 71.26 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - 2.81% -5.53% -2.01% 184.44% 7.04% 8.14% 6.26% 11.31% 10.48% 8.14% PAT Growth - - - - 2,245.96% 0.01% 44.10% -41.26% 13.19% 58.90% EPS - 4.92 -8.66 -3.39 361.52 15.41 15.41 10.69 18.20 16.08 10.12

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds 2,697.33 2,647.18 2,731.93 2,761.67 1,130.73 1,027.15 947.42 906.27 812.95 730.05 Share Capital 14.08 14.08 14.08 14.07 18.18 18.17 18.15 18.13 18.09 18.06 Total Reserves 2,675.50 2,628.28 2,714.02 2,747.01 1,111.11 1,007.83 928.41 887.39 793.86 711.27 Non-Current Liabilities 50.27 29.68 26.79 50.07 70.40 63.66 69.27 73.08 73.42 72.20 Secured Loans 0.00 0.00 0.00 0.33 0.44 0.46 0.22 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 23.49 Long Term Provisions 30.41 23.51 14.60 10.76 25.33 12.58 8.88 7.64 9.19 10.24 Current Liabilities 371.45 348.27 271.50 295.88 301.81 282.61 205.00 227.27 246.34 224.19 Trade Payables 188.57 208.22 192.69 211.51 228.28 189.63 142.63 151.13 159.09 136.78 Other Current Liabilities 168.06 115.02 67.56 60.40 56.73 47.43 36.32 29.71 29.87 29.23 Short Term Borrowings 0.00 15.21 0.00 0.00 0.55 7.90 0.00 0.63 5.72 24.87 Short Term Provisions 14.83 9.81 11.25 23.97 16.25 37.65 26.05 45.80 51.67 33.30 Total Liabilities 3,119.05 3,025.13 3,030.22 3,107.62 1,502.94 1,373.42 1,221.69 1,206.62 1,132.71 1,026.44 Net Block 846.23 824.94 785.16 551.12 464.17 381.20 395.87 393.72 426.22 385.21 Gross Block 1,129.16 1,037.52 939.38 655.08 535.64 414.65 683.53 642.30 637.46 562.43 Accumulated Depreciation 282.93 212.58 154.22 103.96 71.47 33.45 287.67 248.58 211.24 177.22 Non Current Assets 1,813.69 1,520.42 1,177.12 895.56 815.69 744.42 676.73 642.69 671.09 614.20 Capital Work in Progress 567.73 330.84 90.25 235.53 247.26 232.65 118.66 86.31 129.29 111.34 Non Current Investment 287.52 252.77 245.36 86.97 85.16 102.52 117.61 114.25 107.20 91.62 Long Term Loans & Adv. 112.21 111.88 56.36 21.94 19.11 28.05 44.59 48.42 8.38 26.02 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,305.37 1,504.71 1,853.10 2,212.05 687.25 629.00 544.95 563.92 461.63 412.25 Current Investments 236.43 419.10 800.75 895.55 8.00 8.04 35.04 5.67 33.06 14.50 Inventories 386.12 315.57 274.18 207.76 253.98 200.66 186.48 186.24 131.63 141.13 Sundry Debtors 360.48 323.10 331.35 231.74 296.49 264.73 206.19 211.28 212.28 184.82 Cash & Bank 57.59 205.37 191.03 673.61 10.16 10.94 19.71 40.83 16.66 13.86 Other Current Assets 264.75 58.80 63.63 57.89 118.61 144.63 97.52 119.92 68.00 57.93 Short Term Loans & Adv. 207.13 182.77 192.16 145.51 100.40 121.55 80.97 103.50 59.71 51.11 Net Current Assets 933.91 1,156.45 1,581.60 1,916.17 385.44 346.38 339.96 336.65 215.28 188.06 Total Assets 3,119.06 3,025.13 3,030.22 3,107.61 1,502.94 1,373.42 1,221.68 1,206.61 1,132.72 1,026.45

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds 2,556.83 2,531.35 2,619.91 2,680.08 1,063.62 954.33 867.52 816.61 727.07 660.58 Share Capital 14.08 14.08 14.08 14.07 18.18 18.17 18.15 18.13 18.09 18.06 Total Reserves 2,535.00 2,512.44 2,601.99 2,665.42 1,044.00 935.01 848.52 797.74 707.98 641.80 Non-Current Liabilities 49.16 43.72 10.10 46.46 64.49 76.02 74.21 97.72 94.31 92.67 Secured Loans 0.00 0.00 0.00 0.33 0.44 22.98 20.35 24.65 20.89 20.47 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 23.49 Long Term Provisions 30.41 23.51 14.60 10.76 25.33 12.58 8.88 7.64 9.19 10.24 Current Liabilities 505.76 566.73 502.92 463.51 392.62 275.09 211.76 230.32 251.12 233.30 Trade Payables 210.08 250.22 221.41 226.23 210.73 163.95 138.23 150.52 156.63 140.30 Other Current Liabilities 176.97 122.04 68.45 63.03 68.01 60.56 45.86 32.99 36.65 34.28 Short Term Borrowings 100.63 184.03 199.67 150.29 97.62 12.93 1.63 1.04 6.17 25.42 Short Term Provisions 18.09 10.44 13.39 23.97 16.25 37.65 26.05 45.78 51.67 33.30 Total Liabilities 3,111.75 3,141.80 3,132.93 3,190.05 1,520.73 1,305.44 1,153.49 1,144.65 1,072.50 986.55 Net Block 880.42 866.06 806.29 574.45 487.22 402.60 415.99 419.29 447.76 408.39 Gross Block 1,193.56 1,098.27 975.96 689.74 561.37 439.53 724.65 688.25 675.87 599.27 Accumulated Depreciation 313.14 232.21 169.67 115.29 74.15 36.92 308.66 268.96 228.11 190.87 Non Current Assets 1,734.44 1,455.33 1,093.64 853.59 772.27 673.34 589.07 563.97 594.06 547.20 Capital Work in Progress 567.50 330.47 92.39 238.15 249.98 237.13 122.64 90.54 132.20 112.76 Non Current Investment 159.12 134.38 129.20 9.20 9.51 5.54 5.83 5.72 5.72 0.03 Long Term Loans & Adv. 112.89 112.90 56.37 24.05 25.57 28.05 44.61 48.42 8.38 26.02 Other Non Current Assets 14.52 11.52 9.39 7.74 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,377.32 1,686.47 2,039.29 2,336.47 748.46 632.11 564.42 580.68 478.44 439.35 Current Investments 236.43 419.10 800.75 895.55 8.00 8.04 35.04 5.67 33.06 14.50 Inventories 538.34 396.54 338.66 272.86 281.71 230.57 207.68 203.49 143.05 157.96 Sundry Debtors 250.27 390.14 436.05 276.92 315.32 220.09 191.58 196.51 206.95 183.25 Cash & Bank 82.45 233.81 200.99 681.46 16.14 20.13 26.96 52.15 24.64 23.23 Other Current Assets 269.83 63.84 68.65 64.17 127.29 153.28 103.17 122.86 70.75 60.40 Short Term Loans & Adv. 207.62 183.04 194.18 145.51 98.80 122.77 82.25 105.67 61.73 53.14 Net Current Assets 871.56 1,119.74 1,536.37 1,872.95 355.84 357.02 352.66 350.36 227.32 206.05 Total Assets 3,111.76 3,141.80 3,132.93 3,190.06 1,520.73 1,305.45 1,153.49 1,144.65 1,072.50 986.55

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity -32.50 -41.84 -251.30 -66.25 140.78 116.58 88.03 86.87 180.30 129.26 PBT 65.65 -63.81 -19.11 3,249.34 131.60 124.17 81.50 178.82 162.45 105.24 Adjustment 49.68 -6.17 -7.08 -3,214.36 72.37 56.10 36.30 20.38 46.82 37.81 Changes in Working Capital -147.51 25.49 -217.91 -103.24 -35.89 -32.73 -11.59 -74.94 5.77 8.92 Cash after chg. in Working capital -32.19 -44.49 -244.10 -68.27 168.08 147.55 106.21 124.26 215.04 151.97 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.31 2.65 -7.20 2.01 -27.30 -30.97 -18.17 -37.39 -34.74 -22.71 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -80.39 -35.59 -322.63 1,648.30 -131.91 -86.73 -62.18 35.22 -126.60 -110.97 Net Fixed Assets -328.53 -338.73 -139.02 -107.71 -135.60 154.89 -73.58 38.14 -92.98 -106.47 Net Investments 147.92 374.24 -63.59 -889.36 17.40 42.09 -32.73 20.34 -34.14 -5.98 Others 100.22 -71.10 -120.02 2,645.37 -13.71 -283.71 44.13 -23.26 0.52 1.48 Cash from Financing Activity -45.19 -21.02 -44.89 -929.51 -8.95 -38.63 -46.97 -97.92 -50.90 -14.87 Net Cash Inflow / Outflow -158.07 -98.45 -618.82 652.53 -0.08 -8.77 -21.12 24.17 2.80 3.42 Opening Cash & Equivalents 203.08 188.66 660.31 7.77 7.86 19.71 40.83 16.66 13.86 10.44 Closing Cash & Equivalent 52.60 203.08 188.66 660.31 7.77 10.94 19.71 40.83 16.66 13.86

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity 33.10 19.82 -327.77 -112.34 68.19 111.91 78.10 86.73 171.23 124.08 PBT 51.48 -48.21 -57.44 3,241.14 141.25 137.68 77.41 171.17 146.07 94.03 Adjustment 65.65 18.79 6.80 -3,207.66 53.31 39.65 35.57 18.74 47.15 39.37 Changes in Working Capital -69.67 53.58 -264.94 -146.67 -98.65 -34.16 -16.49 -66.32 13.05 13.51 Cash after chg. in Working capital 47.46 24.15 -315.57 -113.20 95.91 143.16 96.49 123.58 206.27 146.91 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -14.36 -4.34 -12.20 0.86 -27.72 -31.25 -18.39 -36.85 -35.04 -22.83 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -73.56 -35.91 -286.01 1,648.33 -127.87 -85.33 -52.34 35.70 -118.45 -101.80 Net Fixed Assets -328.53 -338.73 -139.02 -107.71 -135.60 154.89 -73.58 38.14 -92.98 -106.47 Net Investments 147.92 374.24 -63.59 -889.36 17.40 42.09 -32.73 20.34 -34.14 -5.98 Others 107.05 -71.42 -83.40 2,645.40 -9.67 -282.31 53.97 -22.78 8.67 10.65 Cash from Financing Activity -121.19 -62.30 -2.42 -881.13 59.23 -33.42 -50.95 -94.92 -51.38 -14.21 Net Cash Inflow / Outflow -161.65 -78.40 -616.19 654.86 -0.46 -6.84 -25.19 27.51 1.41 8.07 Opening Cash & Equivalents 231.52 197.05 666.07 11.21 11.67 26.96 52.15 24.64 23.23 15.16 Closing Cash & Equivalent 77.46 231.52 197.05 666.07 11.21 20.13 26.96 52.15 24.64 23.23

Financial Ratios

Consolidated /

Standalone

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 382.01 375.30 387.60 392.55 124.27 112.94 104.28 99.92 89.76 80.75 ROA 1.76% -1.86% 0.29% 110.90% 7.22% 7.74% 5.30% 11.61% 12.00% 8.49% ROE 2.03% -2.10% 0.32% 131.43% 9.64% 10.19% 6.95% 15.82% 16.82% 11.73% ROCE 2.50% -2.32% -0.67% 167.06% 12.33% 12.75% 9.04% 21.01% 20.65% 14.59% Fixed Asset Turnover 1.04 0.92 1.22 2.07 2.99 2.25 1.66 1.64 1.69 1.52 Receivable days 110.99 132.06 105.30 78.26 72.16 69.53 69.33 73.49 71.54 83.25 Inventory Days 113.93 119.00 90.13 68.41 58.46 57.16 61.90 55.15 49.14 62.43 Payable days 75.71 82.50 82.64 118.77 140.05 63.62 59.84 69.69 71.38 71.47 Cash Conversion Cycle 149.21 168.55 112.80 27.91 -9.43 63.06 71.39 58.95 49.31 74.22 Total Debt/Equity 0.00 0.01 0.00 0.00 0.00 0.01 0.00 0.00 0.01 0.07 Interest Cover 51.47 -48.78 -29.97 1027.03 66.88 55.19 35.41 73.06 66.46 32.90

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 362.05 358.85 371.69 380.95 116.88 104.93 95.48 90.02 80.27 73.06 ROA 1.11% -1.94% -0.75% 108.06% 7.68% 8.82% 6.55% 11.56% 11.00% 7.63% ROE 1.37% -2.37% -0.90% 136.04% 10.77% 11.92% 8.95% 16.62% 16.34% 11.16% ROCE 2.12% -1.49% -1.77% 162.77% 13.42% 14.97% 9.29% 21.84% 20.13% 14.03% Fixed Asset Turnover 1.08 1.06 1.43 2.21 3.08 2.32 1.71 1.67 1.71 1.55 Receivable days 94.63 136.61 109.51 78.30 63.41 55.72 58.55 64.53 65.42 76.34 Inventory Days 138.14 121.57 93.93 73.33 60.67 59.32 62.03 55.42 50.47 63.88 Payable days 70.25 76.39 73.41 94.97 104.25 52.00 52.61 62.52 65.77 65.64 Cash Conversion Cycle 162.51 181.78 130.03 56.65 19.82 63.05 67.97 57.43 50.11 74.58 Total Debt/Equity 0.04 0.07 0.08 0.06 0.09 0.04 0.03 0.03 0.04 0.11 Interest Cover 11.12 -5.25 -6.64 405.79 43.00 48.57 26.45 54.66 45.40 24.06

Top Investors:

hdfc small cap fund

krishnaraj venkataraman

iepf

Annual Reports:

News Update:

Unichem Laboratories gets tentative approval for Sitagliptin Tablets
12th Jul 2021, 10:57 AM

The company has received tentative approval from the United States Food and Drug Administration
Read More
Unichem Laboratories gets USFDA’s tentative nod for Aripiprazole Tablets
1st Jul 2021, 10:32 AM

Product will be commercialized from Unichem’s Ghaziabad Plant on receipt of full approval
Read More
Unichem Laboratories gets ANDA approval for Amitriptyline HCl Tablets
20th May 2021, 14:50 PM

The product will be commercialized from Unichem’s Goa Plant
Read More

Unichem Laboratories Ltd.

Pharmaceuticals & Drugs - Global

BSE: 506690 | NSE: UNICHEMLAB

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Unichem Laboratories Ltd.

Pharmaceuticals & Drugs - Global

BSE: 506690 | NSE: UNICHEMLAB

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: